Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study [NA]

View source ↗

Summary

The TRI-V Heart Failure ICD study sponsored by Abbott Medical Devices has completed its trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRI-V Heart Failure ICD

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED